DIH Holdings US, Inc. (DHAI)
NASDAQ: DHAI · IEX Real-Time Price · USD
1.660
+0.190 (12.93%)
At close: Apr 26, 2024, 4:00 PM
1.650
-0.010 (-0.60%)
After-hours: Apr 26, 2024, 7:44 PM EDT
DIH Holdings US Market Cap
DIH Holdings US has a market cap or net worth of $67.55 million as of April 26, 2024. Its market cap has decreased by -41.31% in one year.
Market Cap
67.55M
Enterprise Value
84.50M
1-Year Change
-41.31%
Ranking
Category
Stock Price
$1.66
Market Cap Chart
Since February 7, 2022, DIH Holdings US's market cap has decreased from $250.50M to $67.55M, a decrease of -73.03%. That is a compound annual growth rate of -44.64%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 26, 2024 | 54.90M | 18.83% |
Apr 25, 2024 | 46.20M | 5.00% |
Apr 24, 2024 | 44.00M | 1.62% |
Apr 23, 2024 | 43.30M | -1.59% |
Apr 22, 2024 | 44.00M | 1.85% |
Apr 19, 2024 | 43.20M | 1.17% |
Apr 18, 2024 | 42.70M | 7.56% |
Apr 17, 2024 | 39.70M | 1.28% |
Apr 16, 2024 | 39.20M | -8.20% |
Apr 15, 2024 | 42.70M | 0.95% |
Apr 12, 2024 | 42.30M | 1.44% |
Apr 11, 2024 | 41.70M | 6.92% |
Apr 10, 2024 | 39.00M | 1.56% |
Apr 9, 2024 | 38.40M | 2.67% |
Apr 8, 2024 | 37.40M | 2.75% |
Apr 5, 2024 | 36.40M | -2.93% |
Apr 4, 2024 | 37.50M | 0.27% |
Apr 3, 2024 | 37.40M | 2.75% |
Apr 2, 2024 | 36.40M | -3.45% |
Apr 1, 2024 | 37.70M | 3.57% |
Mar 28, 2024 | 36.40M | 1.11% |
Mar 27, 2024 | 36.00M | 18.42% |
Mar 26, 2024 | 30.40M | -7.03% |
Mar 25, 2024 | 32.70M | -7.63% |
Mar 22, 2024 | 35.40M | -5.35% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Cryo-Cell International | 68.48M |
Champions Oncology | 68.24M |
Carisma Therapeutics | 68.13M |
Journey Medical | 67.77M |
Asensus Surgical | 67.72M |
CollPlant Biotechnologies | 67.47M |
MDxHealth | 67.40M |
Cue Biopharma | 66.40M |